I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 7 studies | 34% ± 17% | |
| ciliated cell | 6 studies | 28% ± 12% | |
| endothelial cell | 6 studies | 21% ± 5% | |
| macrophage | 6 studies | 20% ± 3% | |
| classical monocyte | 5 studies | 22% ± 6% | |
| microglial cell | 5 studies | 26% ± 5% | |
| oligodendrocyte | 5 studies | 19% ± 2% | |
| non-classical monocyte | 4 studies | 24% ± 7% | |
| conventional dendritic cell | 4 studies | 23% ± 5% | |
| basal cell | 4 studies | 32% ± 10% | |
| natural killer cell | 3 studies | 18% ± 3% | |
| B cell | 3 studies | 19% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 21% ± 4% | |
| GABAergic neuron | 3 studies | 29% ± 5% | |
| glutamatergic neuron | 3 studies | 36% ± 9% | |
| goblet cell | 3 studies | 21% ± 3% | |
| intestinal crypt stem cell | 3 studies | 16% ± 1% |
